Pages with the most revisions

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Main Page (13 revisions)
  2. Clinical Epidemiology of Nipah Virus (12 revisions)
  3. Exact calculation of end-of-outbreak probabilities using contact tracing data (6 revisions)
  4. Letter to editor: Serosurvey for Nipah virus in bat population of southern part of India (4 revisions)
  5. Virology and Pathogenesis (4 revisions)
  6. Clinical Manifestations and Management (3 revisions)
  7. Field Epidemiology and Case Analysis (3 revisions)
  8. Zoonotic Ecology and Spillover Dynamics (3 revisions)
  9. Public Health Policy and Outbreak Response (3 revisions)
  10. Optimal control analysis for the Nipah infection with constant and time-varying vaccination and treatment under real data application (2 revisions)
  11. Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis (2 revisions)
  12. Global dynamics of a compartmental model to assess the effect of transmission from deceased (2 revisions)
  13. Projecting vaccine demand and impact for emerging zoonotic pathogens (2 revisions)
  14. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature (1 revision)
  15. Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018 (1 revision)
  16. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge (1 revision)
  17. Genomic characterization, transcriptome analysis, and pathogenicity of the Nipah virus (Indian isolate) (1 revision)
  18. Predictors of mortality among critically ill SARS-CoV-2 infected patients—a retrospective cohort study, Kerala, India (1 revision)
  19. Emerging threat: Nipah virus - A call for global preparedness and vigilance (1 revision)
  20. Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and preexisting severe henipaviruses (1 revision)
  21. Bot Test Page (1 revision)
  22. Nipah Virus Infection Generates Ordered Structures in Cellulo (1 revision)
  23. Nipah Virus: A Multidimensional Update (1 revision)
  24. Combatting emerging infectious diseases from Nipah to COVID-19 in Kerala, India (1 revision)
  25. Structural and functional analysis of the Nipah virus polymerase complex (1 revision)
  26. Navigating Nipah virus: Insights, challenges, and recommendations (1 revision)
  27. Bats and viruses: a death-defying friendship (1 revision)
  28. Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis (1 revision)
  29. First Genomic Evidence of a Henipa-like Virus in Brazil (1 revision)
  30. Nipah Virus Inhibitor Knowledgebase (NVIK): a combined evidence approach to prioritise small molecule inhibitors (1 revision)
  31. A systematic review on Nipah virus: global molecular epidemiology and medical countermeasures development (1 revision)
  32. Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species (1 revision)
  33. Human Exposure to Bats, Rodents and Monkeys in Bangladesh (1 revision)
  34. Jme-2023-109469 (1 revision)
  35. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors (1 revision)
  36. Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus (1 revision)
  37. Nipah Virus Outbreaks in Kerala: An Impending Doom? (1 revision)
  38. A comparative genomic approach to decipher the mutations associated with Nipah viral human isolates from southeast Asia (1 revision)
  39. Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease (1 revision)
  40. Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters (1 revision)
  41. Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh (1 revision)
  42. Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease (1 revision)
  43. Characterization of Nipah Virus from Outbreaks in Bangladesh, 2008–2010 (1 revision)
  44. Nipah virus dynamics in bats and implications for spillover to humans (1 revision)
  45. Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a metaanalysis and systematic review (1 revision)
  46. Detection of Nipah virus in Pteropus medius in 2019 outbreak from Ernakulam district, Kerala, India (1 revision)
  47. Newly outbreak of Nipah virus: epidemiology, symptoms, transmission, diagnostic testing, treatment, and global health concern (1 revision)
  48. 1-s2.0-S0042682207007593-main (1 revision)
  49. From Protein to Pandemic: The Transdisciplinary Approach Needed to Prevent Spillover and the Next Pandemic (1 revision)
  50. Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria (1 revision)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)